wrong, that is the number at time of trial being stopped for robust efficacy. 75% patients in Xtandi arm are still alive. OS difference is not mature because patients are living longer and not a lot of deaths have happened.
More importantly hazard ratio is a Robust .7, showing the rate of events in Xtandi arm is much lower, and better than JNJ's .79 (lower is better)... a HR of 1 means drug neither improves or hurt survival. The further below 1 the less events (deaths) are happening